Effectiveness of Manual Acupuncture and Standard Therapy Compared to Standard Therapy in Gynecological Cancer Pain
1 other identifier
interventional
58
1 country
4
Brief Summary
Cancer patients experience cancer pain as much as 66%. Cancer pain is pain that occurs in patients with neoplastic/malignancy and the source of the pain can come from malignant processes, treatments such as radiotherapy, chemotherapy, and surgery as well as other causes that are not related to malignancy processes. Unresolved pain can reduce the quality and life expectancy of cancer pain patients. The prevalence of cancer itself in Indonesia, the case of cervical cancer itself ranks second after breast cancer. In recent decades, acupuncture analgesics have been widely used to relieve cancer pain, and can also reduce the dose and side effects of analgesics. However, substantially the use of acupuncture in cancer pain is still very rare.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2023
Shorter than P25 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 29, 2023
CompletedFirst Submitted
Initial submission to the registry
August 31, 2023
CompletedFirst Posted
Study publicly available on registry
October 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2023
CompletedJanuary 29, 2024
January 1, 2024
4 months
August 31, 2023
January 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain severity with Visual Analog Scale
Visual Analog Scale (VAS) that score 0 is no pain to 100 the worse pain A higher scale means worse outcomes
Before treatment, After treatment in day 1, day 2, day 3, day 5 and day 7
Secondary Outcomes (2)
Quality of Life with European Organisation for Research and Treatment of Cancer Quality of Life C30
before treatment and 7 day after treatment
Analgetic Usage in dosage and frequency
Before treatment, After treatment in day 1, day 2, day 3, day 5 and day 7
Study Arms (2)
Control
NO INTERVENTIONThe Patient are cancer patient that experience cancer pain that only receive analgetic drug treatment according to WHO Stepledder of Pain
Manual acupuncture and standard Therapy
EXPERIMENTALThe Patient are cancer patient that experience cancer paint that receive analgetic drug treatement according WHO stepledder of pain and receive manual acupuncture
Interventions
Eligibility Criteria
You may qualify if:
- Female 18 to 65 years old
- Gynecocal cancer with pain ≥ 4 acording Visual Analog scale and receive analgetic medicine
- The pain cause by
- direct from cancer
- Treatment proces surgery, radiotherapy, chemotherapy, paliatif treatment, supportive treatment
- Adverse reaction form treatment and intoxication
You may not qualify if:
- emergency case patient with hemodynamic instable
- patient with uncooperative behavior because ith serious psychological disorders, no currently undergoing psychiatric treatment, aggressive behavior, that not allowed for acupuncture.
- Patients with blood clotting disorders, with platelets \<50.000 and in neutropenic condition with \<1000 neutrophils.
- The patient has an allergy to stainless steel acupuncture needles. Wounds at the acupuncture point puncture sites, skin infections in the ears. On patients with eczema on the ears, external otitis or psoriasis.
- There is a tumor in the area that will be stabbed and stimulated in the stomach pregnant women, close to the heart, or in the area of the carotid sinus lymphedema, insertion into the prosthesis.
- Patients with heart rhythm disorders. The patient uses a pace maker.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Fatmawati Hospital
Jakarta, Dki Jakarta, 10430, Indonesia
Persahabatan Hospital
Jakarta, Dki Jakarta, 13230, Indonesia
Suryamin Hung
Jakarta, DKI Jakarta, 14250, Indonesia
Cipto Mangunkusumo Hospital
Jakarta Pusat, Dki Jakarta, 10430, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Suryamin Suryamin
Indonesia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The investigator blind the participant allocation
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
August 31, 2023
First Posted
October 6, 2023
Study Start
August 29, 2023
Primary Completion
December 19, 2023
Study Completion
December 19, 2023
Last Updated
January 29, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share